STOCK TITAN

Insight funds adjust Hinge Health (HNGE) stake with share conversions and sales

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Hinge Health, Inc. large shareholder entities affiliated with Insight reported a combination of share conversions and sales. On June 16, 2026, they converted an aggregate 65,581 shares of Class B Common Stock into Class A Common Stock, then executed open-market sales of 65,581 Class A shares at an average price of $70.3596 per share through indirect holdings noted in the footnotes. Following these transactions, the reported Class A positions in the sale lines were reduced to zero, while significant Class B Common Stock positions remained outstanding as derivative securities.

Positive

  • None.

Negative

  • None.

Insights

Insight-affiliated holders converted and sold 65,581 Hinge Health Class A shares.

Entities associated with Insight Holdings Group, identified as ten percent owners, converted Class B Common Stock into 65,581 Class A shares of Hinge Health and sold the same number of Class A shares in open-market transactions at $70.3596 per share.

The filing shows 0% remaining Class A shares in the reported sale lines, but substantial Class B Common Stock positions continue as derivative securities with large post-transaction balances. The activity appears as a structured convert-and-sell event by institutional holders, with overall impact depending on Hinge Health’s total share base not detailed here.

Insider Insight Holdings Group, LLC, Insight Venture Associates X, Ltd., Insight Venture Associates X, L.P., Insight Venture Partners X, L.P., Insight Venture Partners (Cayman) X, L.P., Insight Venture Partners (Delaware) X, L.P., Insight Venture Partners X (Co-Investors), L.P.
Role null | null | null | null | null | null | null
Sold 65,581 shs ($4.61M)
Type Security Shares Price Value
Conversion Class B Common Stock 32,751 $0.00 --
Conversion Class B Common Stock 779 $0.00 --
Conversion Class B Common Stock 26,856 $0.00 --
Conversion Class B Common Stock 5,195 $0.00 --
Conversion Class A Common Stock 32,751 $0.00 --
Conversion Class A Common Stock 779 $0.00 --
Conversion Class A Common Stock 26,856 $0.00 --
Conversion Class A Common Stock 5,195 $0.00 --
Sale Class A Common Stock 32,751 $70.3596 $2.30M
Sale Class A Common Stock 779 $70.3596 $55K
Sale Class A Common Stock 26,856 $70.3596 $1.89M
Sale Class A Common Stock 5,195 $70.3596 $366K
Holdings After Transaction: Class B Common Stock — 4,649,146 shares (Indirect, See footnotes); Class A Common Stock — 32,751 shares (Indirect, See footnotes)
Footnotes (1)
  1. See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1
Class A shares sold 65,581 shares Total Class A Common Stock sold in open-market transactions on June 16, 2026
Average sale price $70.3596 per share Price for each reported Class A sale transaction on June 16, 2026
Class B converted 65,581 shares Total Class B Common Stock converted into Class A Common Stock on June 16, 2026
Remaining Class B block 4,649,146 shares One reported post-transaction Class B Common Stock balance in an indirect Insight-affiliated holding
Net buy/sell direction net-sell of 65,581 shares Form 4 transaction summary netBuySellShares and netBuySellDirection for Class A trades
open-market sale financial
"transaction_action: "open-market sale" for Class A Common Stock"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative conversion financial
"transaction_action: "derivative conversion" for Class B to Class A"
Class B Common Stock financial
"security_title: "Class B Common Stock" with underlying Class A shares"
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
ten percent owner regulatory
"is_ten_percent_owner: 1 for multiple Insight-affiliated reporting persons"
indirect ownership financial
"direct_or_indirect: "I" and ownership_type: "indirect" with footnote reference"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Insight Holdings Group, LLC

(Last)(First)(Middle)
C/O INSIGHT PARTNERS
1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)
NEW YORK NEW YORK 10036

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
XForm filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock06/16/2026C32,751A(8)32,751ISee footnotes(1)(6)(7)
Class A Common Stock06/16/2026C779A(8)779ISee footnotes(2)(6)(7)
Class A Common Stock06/16/2026C26,856A(8)26,856ISee footnotes(3)(6)(7)
Class A Common Stock06/16/2026C5,195A(8)5,195ISee footnotes(4)(6)(7)
Class A Common Stock06/16/2026S(10)32,751D$70.3596(9)0ISee footnotes(1)(6)(7)
Class A Common Stock06/16/2026S(10)779D$70.3596(9)0ISee footnotes(2)(6)(7)
Class A Common Stock06/16/2026S(10)26,856D$70.3596(9)0ISee footnotes(3)(6)(7)
Class A Common Stock06/16/2026S(10)5,195D$70.3596(9)0ISee footnotes(4)(6)(7)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Class B Common Stock(8)06/16/2026C32,751 (8) (8)Class A Common Stock32,751(5)4,649,146ISee footnotes(1)(6)(7)
Class B Common Stock(8)06/16/2026C779 (8) (8)Class A Common Stock779(5)110,619ISee footnotes(2)(6)(7)
Class B Common Stock(8)06/16/2026C26,856 (8) (8)Class A Common Stock26,856(5)3,812,355ISee footnotes(3)(6)(7)
Class B Common Stock(8)06/16/2026C5,195 (8) (8)Class A Common Stock5,195(5)737,463ISee footnotes(4)(6)(7)
1. Name and Address of Reporting Person*
Insight Holdings Group, LLC

(Last)(First)(Middle)
C/O INSIGHT PARTNERS
1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)
NEW YORK NEW YORK 10036

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Insight Venture Associates X, Ltd.

(Last)(First)(Middle)
C/O INSIGHT PARTNERS
1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)
NEW YORK NEW YORK 10036

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Insight Venture Associates X, L.P.

(Last)(First)(Middle)
C/O INSIGHT PARTNERS
1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)
NEW YORK NEW YORK 10036

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Insight Venture Partners X, L.P.

(Last)(First)(Middle)
C/O INSIGHT PARTNERS
1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)
NEW YORK NEW YORK 10036

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Insight Venture Partners (Cayman) X, L.P.

(Last)(First)(Middle)
C/O INSIGHT PARTNERS
1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)
NEW YORK NEW YORK 10036

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Insight Venture Partners (Delaware) X, L.P.

(Last)(First)(Middle)
C/O INSIGHT PARTNERS
1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)
NEW YORK NEW YORK 10036

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Insight Venture Partners X (Co-Investors), L.P.

(Last)(First)(Middle)
C/O INSIGHT PARTNERS
1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)
NEW YORK NEW YORK 10036

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
Explanation of Responses:
1. See Exhibit 99.1
2. See Exhibit 99.1
3. See Exhibit 99.1
4. See Exhibit 99.1
5. See Exhibit 99.1
6. See Exhibit 99.1
7. See Exhibit 99.1
8. See Exhibit 99.1
9. See Exhibit 99.1
10. See Exhibit 99.1
Remarks:
Exhibit List Exhibit 99.1 - Explanation of Responses Exhibit 99.2 - Joint Filers' Signatures
Insight Holdings Group, LLC06/18/2026
Insight Venture Associates X, Ltd.06/18/2026
Insight Venture Associates X, L.P.06/18/2026
Insight Venture Partners X, L.P.06/18/2026
Insight Venture Partners (Cayman) X, L.P.06/18/2026
Insight Venture Partners (Delaware) X, L.P.06/18/2026
Insight Venture Partners X (Co-Investors), L.P.06/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Insight-affiliated holders do in this HNGE Form 4?

Insight-affiliated entities converted Class B Common Stock into 65,581 Class A shares of Hinge Health, Inc. and sold all 65,581 Class A shares in open-market transactions on June 16, 2026 at an average price of $70.3596 per share.

How many Hinge Health (HNGE) shares were sold by Insight entities?

Insight-related holders sold a total of 65,581 shares of Hinge Health Class A Common Stock. These open-market transactions occurred on June 16, 2026, at an average sale price of $70.3596 per share according to the Form 4 transaction summary data.

What price did Insight-affiliated holders receive for Hinge Health Class A shares?

The reported Hinge Health Class A Common Stock sales by Insight-affiliated entities were executed at an average price of $70.3596 per share. Each of the four sale transactions disclosed in the Form 4 shows this same per-share transaction price on June 16, 2026.

Did Insight entities acquire or dispose of Hinge Health shares overall?

Overall, Insight-affiliated entities reported a mixed pattern: they acquired 65,581 Class A shares via conversions of Class B, then disposed of 65,581 Class A shares in open-market sales. The net effect was a reported net sell direction for the Class A position in this filing.

Do Insight-affiliated holders still own Hinge Health Class B shares after these trades?

Yes. While 65,581 Class B shares were converted into Class A and sold, the Form 4 shows remaining Class B Common Stock balances, such as 4,649,146 shares in one line, indicating substantial ongoing indirect holdings in Hinge Health by Insight-related entities.